Fidelity Investments’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-52,740
| Closed | -$526K | – | 5488 |
|
|
2025
Q2 | $526K | Buy |
52,740
+48,861
| +1,260% | +$394K | ﹤0.01% | 2945 |
|
|
2025
Q1 | $23.2K | Sell |
3,879
-6,856
| -64% | -$50.3K | ﹤0.01% | 4171 |
|
|
2024
Q4 | $82.4K | Buy |
10,735
+8,886
| +481% | +$76.4K | ﹤0.01% | 3634 |
|
|
2024
Q3 | $18.9K | Sell |
1,849
-319
| -15% | -$4.87K | ﹤0.01% | 4199 |
|
|
2024
Q2 | $32.2K | Buy |
2,168
+437
| +25% | +$6.26K | ﹤0.01% | 3841 |
|
|
2024
Q1 | $23.6K | Sell |
1,731
-139,811
| -99% | -$1.52M | ﹤0.01% | 3949 |
|
|
2023
Q4 | $1.55M | Buy |
141,542
+879
| +0.6% | +$8.71K | ﹤0.01% | 2356 |
|
|
2023
Q3 | $1.54M | Sell |
140,663
-54
| -0% | -$691 | ﹤0.01% | 2352 |
|
|
2023
Q2 | $1.86M | Sell |
140,717
-71,998
| -34% | -$1.03M | ﹤0.01% | 2335 |
|
|
2023
Q1 | $2.9M | Sell |
212,715
-142,283
| -40% | -$2.55M | ﹤0.01% | 2266 |
|
|
2022
Q4 | $6.93M | Sell |
354,998
-91,279
| -20% | -$1.78M | ﹤0.01% | 2025 |
|
|
2022
Q3 | $8.5M | Buy |
446,277
+15,081
| +3% | +$347K | ﹤0.01% | 1974 |
|
|
2022
Q2 | $8.88M | Sell |
431,196
-182,341
| -30% | -$4.33M | ﹤0.01% | 2019 |
|
|
2022
Q1 | $19.7M | Sell |
613,537
-181,944
| -23% | -$6.61M | ﹤0.01% | 1784 |
|
|
2021
Q4 | $37M | Sell |
795,481
-9,600
| -1% | -$320K | ﹤0.01% | 1550 |
|
|
2021
Q3 | $21.7M | Sell |
805,081
-5,700
| -0.7% | -$149K | ﹤0.01% | 1806 |
|
|
2021
Q2 | $20.8M | Sell |
810,781
-9,300
| -1% | -$222K | ﹤0.01% | 1837 |
|
|
2021
Q1 | $28M | Buy |
820,081
+83,200
| +11% | +$3.01M | ﹤0.01% | 1641 |
|
|
2020
Q4 | $24.9M | Buy |
736,881
+98,681
| +15% | +$2.61M | ﹤0.01% | 1610 |
|
|
2020
Q3 | $15.7M | Buy |
+638,200
| New | +$17.2M | ﹤0.01% | 1676 |
|
Other funds holding ITOS
Fidelity Investments's ITOS Position: Q3 2025 in Review
Fidelity Investments sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 52,740 shares — an estimated $526K sold.
Fidelity Investments first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $37M in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Fidelity Investments reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Fidelity Investments sold 52,740 iTeos Therapeutics shares in Q3 2025, an estimated $526K.
- Fidelity Investments first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- Fidelity Investments's iTeos Therapeutics position peaked at $37M in Q4 2021.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.